Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - August 04, 2016) - Abeona Therapeutics, Inc. (NASDAQ: ABEO) Approval of clinical trial for ABO-102 (AAV-SGSH) in European Union marks 3rd regulatory...
-
NUEVA YORK, NY Y CLEVELAND, OH--(Marketwired - 2 de agosto de 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO)ABO-102 (AAV-SGSH) es la primera genoterapia basada en un virus adenoasociado (VAA)...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - August 02, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO)ABO-102 (AAV-SGSH) delivers first-in-man AAV-based gene therapy delivered by single...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - June 30, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) a clinical-stage biopharmaceutical company focused on delivering gene therapy and plasma-based...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - June 07, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on delivering gene therapy and plasma-based...
-
NEW YORK, NY AND CLEVELAND, OH--(Marketwired - June 02, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) a clinical-stage biopharmaceutical company focused on delivering gene therapy and...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - May 24, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) ABO-101 is Abeona's second AAV gene therapy to commence clinical trials in a rare CNS...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - May 23, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing and delivering gene...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - May 17, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing products for severe and...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - May 16, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing and delivering gene...